Safety and Efficacy of Anti-TNF Therapy in Older Adults With Ulcerative Colitis: A New Path Forward

Gastroenterology. 2022 May;162(6):1762-1764. doi: 10.1053/j.gastro.2021.12.003. Epub 2021 Dec 2.

Authors

Adam S Faye¹, John A Dodson¹, Aasma Shaukat¹

Affiliation

¹ Department of Medicine, New York University School of Medicine, New York, New York.

PMID: 34864071
DOI: 10.1053/j.gastro.2021.12.003

No abstract available

Publication types

Comment

MeSH terms

Aged
Antibodies, Monoclonal / adverse effects
Colitis, Ulcerative* / diagnosis
Colitis, Ulcerative* / drug therapy
Humans
Immunotherapy
Infliximab / adverse effects
Tumor Necrosis Factor Inhibitors / adverse effects
Tumor Necrosis Factor-alpha

Substances

Antibodies, Monoclonal
Tumor Necrosis Factor Inhibitors
Tumor Necrosis Factor-alpha
Infliximab